Effectiveness and Cost-effectiveness of Doin (Conduction Exercise) for Chronic Neck Pain
The Effectiveness and Cost-effectiveness of Doin (Conduction Exercise) for Chronic Neck Pain: a Pilot Multicenter Randomized Controlled Clinical Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
A pilot multicenter randomized controlled trial will be conducted to evaluate the clinical effectiveness, cost-effectiveness, and safety of Doin (conduction exercise) with acupuncture for chronic neck pain patients compared to acupuncture alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 28, 2016
CompletedFirst Posted
Study publicly available on registry
January 4, 2017
CompletedStudy Start
First participant enrolled
February 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 23, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 22, 2018
CompletedNovember 7, 2018
November 1, 2018
6 months
December 28, 2016
November 6, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Northwick Park Neck Pain Questionnaire (NPQ)
Change in pain and functional disability questionnaire
6 weeks from baseline
Secondary Outcomes (11)
Northwick Park Neck Pain Questionnaire (NPQ)
Baseline (Week 1), Week 4, 6, 9, 17, 29, 53
Numeric rating scale (NRS) of neck and arm pain
Baseline (Week 1), Week 2, 3, 4, 5, 6, 9, 17, 29, 53
Visual analogue scale (VAS) of neck and arm pain
Baseline (Week 1), Week 2, 3, 4, 5, 6
Neck Disability Index (NDI)
Baseline (Week 1), Week 4, 6, 9, 17, 29, 53
EuroQol-5 Dimension (EQ-5D)
Baseline (Week 1), Week 4, 6, 9, 17, 29, 53
- +6 more secondary outcomes
Study Arms (2)
Doin with Acupuncture
EXPERIMENTALAn acupuncture physician will administer acupuncture at 6-12 acupoints in the upper and middle trapezius area (mandatory points: both SI15, TE15, and LI16; and selective points: GB20, BL10, GV14, SI14, and Hyeopcheok (Huatuo Jiaji, EX B2) points at C3-5 levels). Cervical Doin (conduction exercise) will be performed with the needles in situ by increasing the cervical range of motion (rotation) with physician guidance and isometric resistance exercise (rotation) as needed.
Acupuncture
ACTIVE COMPARATORAn acupuncture physician will administer acupuncture at 6-12 acupoints in the upper and middle trapezius area (mandatory points: both SI15, TE15, and LI16; and selective points: GB20, BL10, GV14, SI14, and Hyeopcheok (Huatuo Jiaji, EX B2) points at C3-5 levels).
Interventions
Doin (conduction exercise) will be combined with acupuncture as active and passive movement to the aim of effective treatment of pain and functional disability. Doin (conduction exercise) sessions will be conducted 2 times a week for 5 weeks.
Acupuncture will be performed with manual stimulation (needle twirling) to evoke de-qi sensation. Acupuncture sessions will be conducted 2 times a week for 5 weeks.
Eligibility Criteria
You may qualify if:
- Onset of at least 6 months previous for neck area pain
- Current neck area pain of Numeric Rating Scale (NRS) 5 or higher
- Patients who have agreed to voluntarily participate in the clinical trial and given written informed consent
You may not qualify if:
- Pathologies of non-spinal or soft tissue origin or high severity which may cause neck or radiating arm pain (e.g. malignant tumor, spinal infection, inflammatory spondylitis, fibromyalgia, rheumatic arthritis, gout)
- Progressive neurologic deficit or severe neurologic symptoms (e.g. cauda equina syndrome, progressive muscle weakness)
- Other chronic diseases which may interfere with treatment effect or interpretation of results (e.g. cardiovascular disorder, renal disease, diabetic neuropathy, dementia, epilepsy)
- Current intake of steroids, immunosuppressant medicine, psychiatric medicine or other medication which may interfere with treatment results
- Patients considered unsuitable or unsafe to receive acupuncture (e.g. patients with hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine intake, severe diabetes with high risk of infection, severe cardiovascular diseases)
- Patients who were treated with invasive interventions such as acupuncture or injections, or with medicine that may potentially influence pain such as NSAIDs (nonsteroidal antiinflammatory drugs) within the past week
- History of cervical surgery within the past 3 months
- Pregnancy or plans of pregnancy
- Severe psychopathy
- Participation in other clinical studies
- Inability to give written informed consent
- Other reasons rendering trial participation inappropriate as judged by the researchers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jaseng Medical Foundation
Seoul, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
In-Hyuk Ha, KMD, MPH
Jaseng Medical Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
December 28, 2016
First Posted
January 4, 2017
Study Start
February 27, 2017
Primary Completion
August 23, 2017
Study Completion
August 22, 2018
Last Updated
November 7, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share